Cargando…
PRMT5 is a therapeutic target in choroidal neovascularization
Ocular neovascular diseases including neovascular age-related macular degeneration (nvAMD) are widespread causes of blindness. Patients’ non-responsiveness to currently used biologics that target vascular endothelial growth factor (VEGF) poses an unmet need for novel therapies. Here, we identify pro...
Autores principales: | Muniyandi, Anbukkarasi, Martin, Matthew, Sishtla, Kamakshi, Motolani, Aishat, Sun, Mengyao, Jensen, Nathan R., Qi, Xiaoping, Boulton, Michael E., Prabhu, Lakshmi, Lu, Tao, Corson, Timothy W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889383/ https://www.ncbi.nlm.nih.gov/pubmed/36720900 http://dx.doi.org/10.1038/s41598-023-28215-w |
Ejemplares similares
-
An improved method for murine laser-induced choroidal neovascularization lesion quantification from optical coherence tomography images
por: Jensen, Nathan R., et al.
Publicado: (2022) -
Decreased Expression of Soluble Epoxide Hydrolase Suppresses Murine Choroidal Neovascularization
por: Park, Bomina, et al.
Publicado: (2022) -
Retinal Phenotyping of Ferrochelatase Mutant Mice Reveals Protoporphyrin Accumulation and Reduced Neovascular Response
por: Sardar Pasha, S. P. B., et al.
Publicado: (2021) -
The Structure and Functions of PRMT5 in Human Diseases
por: Motolani, Aishat, et al.
Publicado: (2021) -
A complex signature network that controls the upregulation of PRMT5 in colorectal cancer
por: Wei, Han, et al.
Publicado: (2021)